Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.20 +0.27 (+1.13%)
Official Closing Price Updated: 7:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Pfizer's Options Frenzy: What You Need to Know
Via Benzinga
Pfizer (PFE) Q2 2024 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact from the 2026 Medicare drug price cuts, easing initial industry concerns. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Of The Day: Pfizer Pattern Offers Lessons After Better-Than-Expected Q2 Results
Like many things on Wall Street, technical analysis is widely misunderstood. Many analysts try to identify chart patterns without understanding the psychology and price action that creates them. This... 
Via Benzinga
Pfizer $PFE Beats Earnings Estimates
Pfizer $PFE Beats Earnings Estimates and Raises Full-Year Outlook Amid Cost-Cutting Measures 
Via Chartmill
(PFE) - Analyzing Pfizer's Short Interest
Via Benzinga
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday?
Investor sentiment took a hit on Tuesday as caution prevailed ahead of significant market events, including key tech earnings reports and the Federal Open Market Committee meeting. 
Via Benzinga
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
The market for vaccines and treatments used in managing COVID-19 has shrunk by billions of dollars a year. Forced to rebuild their business, pharmaceutical companies like Pfizer Inc (NYSE: PFE)... 
Via Benzinga
Exposures COVID-19
PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q2 2024
PFE stock results show that Pfizer beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Dow Jumps 200 Points; Pfizer Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Pfizer Marks First Revenue Growth Since COVID Revenue Peak In 2022, Lifts Annual Guidance
Pfizer reports Q2 adjusted EPS of $0.60, beating the $0.46 consensus. Sales reached $13.28 billion, driven by acquired products and new launches, despite a decline in Comirnaty. Updated 2024 revenue... 
Via Benzinga
Exposures COVID-19
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks." 
Via Benzinga
Pfizer Inc. Beats Q2 Market Expectations With $13.3 Billion In Revenue
Pfizer Inc. reported a strong Q2 performance in 2024, with total revenues reaching $13.3 billion. 
Via Talk Markets
Nasdaq, S&P Futures Rise As Microsoft, AMD Earnings Take Spotlight: Will Fed Provide 'Turbo Boost' For Market? Analyst Weighs In
Wall Street is likely to tenaciously hold onto the slender optimism ahead of a slew of earnings from notable companies and the Federal Reserve’s two-day rate-setting meeting that gets underway on... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Pfizer Stock Rises On Earnings Beat, Raised Outlook
The drug giant's EPS fell vs. a year earlier, but revenue topped. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
The healthcare sector, represented by the XLV ETF, has seen a resurgence, breaking out of a multi-year consolidation phase and surging almost 3% in July. 
Via MarketBeat
Topics ETFs
Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidance
From Pfizer Inc.
Via Business Wire
10 Best Ultra-High-Yield Dividend Stocks to Consider as Part of a Long-Term Portfolio
These ultra-high-yield dividend stocks could be a great fit for a long-term-oriented portfolio. 
Via The Motley Fool
Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?
A lowered outlook for 2024 and upcoming patent expirations have investors concerned about this pharmaceutical giant's dividend program. 
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
US Stocks Close Mixed Ahead Of Big Earnings, Fed Decision: Investor Optimism Improves Further
Via Benzinga
Topics Economy
Exposures Interest Rates
Procter & Gamble, Microsoft And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings
Pfizer Inc (PFE) expected to release Q2 financial results on Tuesday before opening bell. Analysts predict earnings at 46 cents/share, down from 67 cents last year. Stock gained 3.4% to close at $30.77... 
Via Benzinga
Prediction: This Will Be Pfizer's Next Big Move
One market in particular is too lucrative for it to miss out on any longer. 
Via The Motley Fool
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold Forever
Any of these three stocks could be the backbone of a solid dividend portfolio. 
Via The Motley Fool
2 Incredibly Cheap Healthcare Stocks to Buy Now
Sometimes a beaten-down stock can present a valuable opportunity. 
Via The Motley Fool
2 High-Yield Dividend Stocks That Could Shine in 2025
With interest rates expected to decline, high-yield dividend stocks offer attractive income potential and possible capital appreciation. 
Via The Motley Fool
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.